Shopping Cart
- Remove All
Your shopping cart is currently empty
XL44
XL44, as an hRpn13 binder, triggers hRpn13-dependent apoptosis and limits cell viability via a PCLAF-dependent mechanism. It causes ubiquitin-dependent degradation of hRpn13 Pru and ubiquitin-independent degradation of specific KEN box-containing proteins [1].
Catalog No. T87644Cas No. 2637949-91-6
Resource Download
XL44
Catalog No. T87644Cas No. 2637949-91-6
XL44, as an hRpn13 binder, triggers hRpn13-dependent apoptosis and limits cell viability via a PCLAF-dependent mechanism. It causes ubiquitin-dependent degradation of hRpn13 Pru and ubiquitin-independent degradation of specific KEN box-containing proteins [1].
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose. | Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks |
Bulk & Custom
Add to Cart
Questions
View MoreProduct Introduction
Bioactivity
Chemical Properties
| Description | XL44, as an hRpn13 binder, triggers hRpn13-dependent apoptosis and limits cell viability via a PCLAF-dependent mechanism. It causes ubiquitin-dependent degradation of hRpn13 Pru and ubiquitin-independent degradation of specific KEN box-containing proteins [1]. |
| In vitro | XL44, when applied at a concentration of 20 μM to RPMI 8226 cell lysates over a period of 4-24 hours, triggers apoptosis through an hRpn13-dependent mechanism and diminishes hRpn13Pru levels [1]. Western Blot Analysis confirms these findings [1]. |
| Molecular Weight | 388.39 |
| Formula | C23H17FN2O3 |
| Cas No. | 2637949-91-6 |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy XL44 | purchase XL44 | XL44 cost | order XL44 | XL44 chemical structure | XL44 in vitro | XL44 formula | XL44 molecular weight
- TOP
Feedback
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.